Simeprevir for the treatment of hepatitis C virus infection

Detailed bibliographic record

Summary, etc.：: Simeprevir (TMC435, Olysio™), a second-generation hepatitis C virus (HCV) protease inhibitor, has been recently approved for the treatment of genotype...

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

CiNii Research
Search Service
Digital
You can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.
Check the holdings of this book

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Material Type: 記事
Title: Simeprevir for the treatment of hepatitis C virus infection
Author Heading: François Helle
Gilles Duverlie
Catherine François
Sandrine Castelain
Laure Izquierdo
Etienne Brochot
Publication Date: 2014-08-01
Publication Date (W3CDTF): 2014-08-01
Periodical title: Pharmacogenomics and Personalized Medicine
Pages: 241-
Publication date of volume/issue (W3CDTF): 2014-08-01
Publication (Periodical Title): Informa UK Limited
Subject Heading: Pharmacogenomics and Personalized Medicine
Therapeutics. Pharmacology
RM1-950
Review
Target Audience: 一般
Standard No. (Other): PMID : 25206310
DOI: 10.2147/pgpm.s52715
https://doi.org/10.2147/pgpm.s52715
Access Restrictions: インターネット公開
References: Faculty Opinions recommendation of Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial.
https://cir.nii.ac.jp/crid/1880865118275754880
Data Provider (Database): 国立情報学研究所 : CiNii Research
https://cir.nii.ac.jp/
Original Data Provider (Database)